Total Payments
$47,871
2024 Payments
$18,773
Companies
5
Transactions
37
Medicare Patients
590
Medicare Billing
$49,764
Payment Breakdown by Category
Consulting$33,913 (70.8%)
Other$7,200 (15.0%)
Travel$5,500 (11.5%)
Food & Beverage$1,159 (2.4%)
Education$99.99 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $33,913 | 11 | 70.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,200 | 2 | 15.0% |
| Travel and Lodging | $5,500 | 7 | 11.5% |
| Food and Beverage | $1,159 | 16 | 2.4% |
| Education | $99.99 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eisai Co., Ltd. | $26,573 | 15 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $13,408 | 11 | $0 (2024) |
| Janssen Global Services, LLC | $7,601 | 8 | $0 (2024) |
| Harmony Biosciences LLC | $209.99 | 2 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $80.03 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18,773 | 15 | IDORSIA PHARMACEUTICALS US INC ($9,972) |
| 2023 | $3,646 | 7 | IDORSIA PHARMACEUTICALS US INC ($3,436) |
| 2022 | $691.60 | 2 | EISAI INC. ($691.60) |
| 2021 | $1,800 | 1 | Eisai Inc. ($1,800) |
| 2020 | $16,425 | 5 | Eisai Inc. ($16,425) |
| 2019 | $4,830 | 4 | Eisai Inc. ($4,750) |
| 2018 | $1,706 | 3 | EISAI INC. ($1,706) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | Eisai Co., Ltd. | Dayvigo (Drug) | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| Category: Neurology | ||||||
| 09/12/2024 | Janssen Global Services, LLC | — | Travel and Lodging | Cash or cash equivalent | $77.43 | General |
| 08/21/2024 | Janssen Global Services, LLC | — | Consulting Fee | Cash or cash equivalent | $6,412.50 | General |
| 08/03/2024 | Janssen Global Services, LLC | — | Food and Beverage | In-kind items and services | $60.00 | General |
| 08/03/2024 | Janssen Global Services, LLC | — | Food and Beverage | In-kind items and services | $59.97 | General |
| 08/03/2024 | Janssen Global Services, LLC | — | Food and Beverage | In-kind items and services | $39.99 | General |
| 08/02/2024 | Janssen Global Services, LLC | — | Travel and Lodging | In-kind items and services | $629.34 | General |
| 08/02/2024 | Janssen Global Services, LLC | — | Travel and Lodging | In-kind items and services | $171.47 | General |
| 08/02/2024 | Janssen Global Services, LLC | — | Food and Beverage | In-kind items and services | $149.99 | General |
| 06/03/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $87.50 | General |
| Category: Insomnia | ||||||
| 05/16/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $62.50 | General |
| Category: Insomnia | ||||||
| 02/12/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Consulting Fee | Cash or cash equivalent | $5,225.00 | General |
| Category: Insomnia | ||||||
| 02/12/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $4,159.35 | General |
| Category: Insomnia | ||||||
| 02/12/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $399.96 | General |
| Category: Insomnia | ||||||
| 02/12/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $37.77 | General |
| Category: Insomnia | ||||||
| 11/02/2023 | Harmony Biosciences LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $110.00 | General |
| Category: SLEEP MEDICINE | ||||||
| 10/24/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $42.76 | General |
| Category: INSOMNIA | ||||||
| 08/17/2023 | Harmony Biosciences LLC | WAKIX (Drug) | Education | Cash or cash equivalent | $99.99 | General |
| Category: SLEEP MEDICINE | ||||||
| 02/28/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $34.71 | General |
| Category: INSOMNIA | ||||||
| 02/15/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $33.33 | General |
| Category: INSOMNIA | ||||||
| 01/20/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Consulting Fee | Cash or cash equivalent | $3,300.00 | General |
| Category: INSOMNIA | ||||||
| 01/20/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | Cash or cash equivalent | $25.00 | General |
| Category: INSOMNIA | ||||||
| 03/16/2022 | EISAI INC. | Dayvigo (Drug) | Consulting Fee | Cash or cash equivalent | $675.00 | General |
| Category: Neurology | ||||||
| 03/16/2022 | EISAI INC. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $16.60 | General |
| Category: Neurology | ||||||
| 01/11/2021 | Eisai Inc. | Dayvigo (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 135 | 233 | $50,707 | $13,930 |
| 2022 | 5 | 159 | 251 | $44,110 | $11,877 |
| 2021 | 4 | 145 | 243 | $41,543 | $12,442 |
| 2020 | 4 | 151 | 228 | $40,203 | $11,515 |
Total Patients
590
Total Services
955
Medicare Billing
$49,764
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 17 | 73 | $18,980 | $4,903 | 25.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 42 | 50 | $11,113 | $3,716 | 33.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 54 | 74 | $11,903 | $3,232 | 27.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 11 | 25 | $4,750 | $1,059 | 22.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 11 | 11 | $3,961 | $1,021 | 25.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 17 | 51 | $13,260 | $3,015 | 22.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 44 | 58 | $8,131 | $2,800 | 34.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 34 | 37 | $5,050 | $2,040 | 40.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 33 | 57 | $8,265 | $1,875 | 22.7% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 19 | 36 | $6,840 | $1,184 | 17.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 12 | 12 | $2,564 | $963.46 | 37.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 15 | 56 | $14,560 | $3,468 | 23.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 31 | 64 | $8,846 | $2,772 | 31.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 40 | 54 | $7,542 | $2,754 | 36.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 45 | 53 | $7,235 | $2,545 | 35.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 14 | 16 | $3,360 | $901.89 | 26.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 15 | 55 | $14,300 | $3,304 | 23.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 25 | 41 | $4,715 | $2,270 | 48.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 32 | 35 | $7,350 | $2,043 | 27.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 23 | 27 | $3,651 | $1,150 | 31.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 15 | 15 | $3,150 | $998.85 | 31.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 25 | 36 | $5,202 | $938.70 | 18.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 16 | 19 | $1,835 | $811.62 | 44.2% |
About Dr. David Neubauer, M.D
Dr. David Neubauer, M.D is a Psychiatry healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427001296.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Neubauer, M.D has received a total of $47,871 in payments from pharmaceutical and medical device companies, with $18,773 received in 2024. These payments were reported across 37 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($33,913).
As a Medicare-enrolled provider, Neubauer has provided services to 590 Medicare beneficiaries, totaling 955 services with total Medicare billing of $49,764. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Baltimore, MD
- Active Since 05/19/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1427001296
Products in Payments
- Dayvigo (Drug) $20,117
- QUVIVIQ (Drug) $13,408
- WAKIX (Drug) $209.99
- None (Drug) $20.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Baltimore
John Vaeth, Md, MD
Psychiatry — Payments: $2.0M
Psychiatry $2.0M
Scott Aaronson, M.d, M.D
Psychiatry — Payments: $414,719
Psychiatry $414,719
Dr. Robert Lehman, M.d, M.D
Psychiatry — Payments: $210,729
Psychiatry $210,729
Paul Rosenberg, M.d, M.D
Psychiatry — Payments: $162,959
Psychiatry $162,959
Dr. Karen Anderson, M.d, M.D
Psychiatry — Payments: $158,684
Psychiatry $158,684
Orlando Davis, M.d, M.D
Psychiatry — Payments: $131,372
Psychiatry $131,372